Rather we have shown that the small molecule ANO1-inhibitor CaCCinh-A01 decreases HNSCC cell viability by facilitating the ER-associated, proteasomal degradation of ANO1, thereby reducing ANO1 protein levels and hence EGFR-signaling in the cells [33, 39]. This evidence concerns the gene ANO1 and head and neck squamous cell carcinoma.